李 岡遠

Medicine & Life Sciences

1. Chronic Obstructive Pulmonary Disease 100%
2. Air Pollution 60%
3. Non-Small Cell Lung Carcinoma 58%
4. Lung 48%
5. Lung Neoplasms 46%
6. Particulate Matter 42%
7. Adenocarcinoma of Lung 32%
8. Tuberculosis 29%
9. Asthma 26%
10. Protein-Tyrosine Kinases 25%
11. Emphysema 25%
12. Myeloid-Derived Suppressor Cells 23%
13. Neoplasms 22%
14. Inflammation 21%
15. Obstructive Sleep Apnea 21%
16. ErbB Receptors 20%
17. Pulmonary Tuberculosis 18%
18. Interleukin-1 18%
19. Macrophages 18%
20. durvalumab 17%
21. Pneumonia 17%
22. Pleural Effusion 17%
23. Exercise 15%
24. Therapeutics 15%
25. Interleukin-8 15%
26. Nanoparticles 15%
27. Smooth Muscle Myocytes 14%
28. Survival 14%
29. Leukocyte Elastase 14%
30. Arousal 13%
31. Ligands 13%
32. Coronavirus 13%
33. Neutrophils 13%
34. Proteomics 13%
35. Proteins 13%
36. Sleep 12%
37. Population 12%
38. Bronchoscopy 12%
39. Mutation 12%
40. Machine Learning 12%
41. Blood Cells 12%
42. Confidence Intervals 12%
43. T-Lymphocytes 11%
44. Alveolar Epithelial Cells 11%
45. Epiregulin 11%
46. Cohort Studies 11%
47. Smooth Muscle 11%
48. inter-alpha-inhibitor 11%
49. Up-Regulation 11%
50. Lung Injury 10%